Adelina Stoyanova

Acad. Georgi Bonchev Street
Sofia, Bulgaria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication in vitro and in vivo.

Journal: NAR molecular medicine

Published: October 31, 2025

In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection.

In Vivo and In Vitro Studies Assessing the Antiviral Efficacy of Double Combinations Against Coxsackievirus B Infection.

Journal: Microorganisms

Published: December 20, 2024

Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures.

Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures.

Journal: Cellular and molecular life sciences : CMLS

Published: July 25, 2024

The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.

The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.

Journal: Antiviral research

Published: January 03, 2024

Effect of castalagin against HSV-1 infection in newborn mice.

Effect of castalagin against HSV-1 infection in newborn mice.

Journal: Natural product research

Published: January 30, 2023

Effects of double combinations of enterovirus replication inhibitors against Coxsackie B viruses.

Effects of double combinations of enterovirus replication inhibitors against Coxsackie B viruses.

Journal: Acta virologica

Published: January 03, 2022

Consecutive alternating administration as an effective anti-coxsackievirus B3 in vivo treatment scheme.

Consecutive alternating administration as an effective anti-coxsackievirus B3 in vivo treatment scheme.

Journal: Archives of virology

Published: January 12, 2021

Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.

Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.

Journal: Pathogens and disease

Published: July 27, 2020

Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice.

Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice.

Journal: Antiviral chemistry & chemotherapy

Published: February 12, 2020

Anti-enteroviral activity of new MDL-860 analogues: Synthesis, in vitro/in vivo studies and QSAR analysis.

Anti-enteroviral activity of new MDL-860 analogues: Synthesis, in vitro/in vivo studies and QSAR analysis.

Journal: Bioorganic chemistry

Published: November 22, 2018

Synthesis and anti-enterovirus activity of new analogues of MDL-860.

Synthesis and anti-enterovirus activity of new analogues of MDL-860.

Journal: Bioorganic & medicinal chemistry letters

Published: July 01, 2017

Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Journal: Antiviral chemistry & chemotherapy

Published: November 06, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026